Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates

J. Bosák, M. Lexa, K. Fiedorová, DC. Gadara, L. Micenková, Z. Spacil, J. Litzman, T. Freiberger, D. Šmajs

. 2021 ; 12 (-) : 671239. [pub] 20210514

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004346

Common variable immunodeficiency (CVID) is a clinically and genetically heterogeneous disorder with inadequate antibody responses and low levels of immunoglobulins including IgA that is involved in the maintenance of the intestinal homeostasis. In this study, we analyzed the taxonomical and functional metagenome of the fecal microbiota and stool metabolome in a cohort of six CVID patients without gastroenterological symptomatology and their healthy housemates. The fecal microbiome of CVID patients contained higher numbers of bacterial species and altered abundance of thirty-four species. Hungatella hathewayi was frequent in CVID microbiome and absent in controls. Moreover, the CVID metagenome was enriched for low-abundance genes likely encoding nonessential functions, such as bacterial motility and metabolism of aromatic compounds. Metabolomics revealed dysregulation in several metabolic pathways, mostly associated with decreased levels of adenosine in CVID patients. Identified features have been consistently associated with CVID diagnosis across the patients with various immunological characteristics, length of treatment, and age. Taken together, this initial study revealed expansion of bacterial diversity in the host immunodeficient conditions and suggested several bacterial species and metabolites, which have potential to be diagnostic and/or prognostic CVID markers in the future.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004346
003      
CZ-PrNML
005      
20220127145326.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2021.671239 $2 doi
035    __
$a (PubMed)34054845
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bosák, Juraj $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
245    10
$a Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates / $c J. Bosák, M. Lexa, K. Fiedorová, DC. Gadara, L. Micenková, Z. Spacil, J. Litzman, T. Freiberger, D. Šmajs
520    9_
$a Common variable immunodeficiency (CVID) is a clinically and genetically heterogeneous disorder with inadequate antibody responses and low levels of immunoglobulins including IgA that is involved in the maintenance of the intestinal homeostasis. In this study, we analyzed the taxonomical and functional metagenome of the fecal microbiota and stool metabolome in a cohort of six CVID patients without gastroenterological symptomatology and their healthy housemates. The fecal microbiome of CVID patients contained higher numbers of bacterial species and altered abundance of thirty-four species. Hungatella hathewayi was frequent in CVID microbiome and absent in controls. Moreover, the CVID metagenome was enriched for low-abundance genes likely encoding nonessential functions, such as bacterial motility and metabolism of aromatic compounds. Metabolomics revealed dysregulation in several metabolic pathways, mostly associated with decreased levels of adenosine in CVID patients. Identified features have been consistently associated with CVID diagnosis across the patients with various immunological characteristics, length of treatment, and age. Taken together, this initial study revealed expansion of bacterial diversity in the host immunodeficient conditions and suggested several bacterial species and metabolites, which have potential to be diagnostic and/or prognostic CVID markers in the future.
650    _2
$a adenosin $x metabolismus $7 D000241
650    _2
$a biodiverzita $7 D044822
650    _2
$a Clostridiaceae $x fyziologie $7 D000073561
650    _2
$a běžná variabilní imunodeficience $x genetika $x mikrobiologie $7 D017074
650    _2
$a výpočetní biologie $x metody $7 D019295
650    _2
$a dysbióza $x genetika $x mikrobiologie $7 D064806
650    _2
$a feces $x mikrobiologie $7 D005243
650    _2
$a střevní mikroflóra $x genetika $7 D000069196
650    _2
$a homeostáza $7 D006706
650    _2
$a lidé $7 D006801
650    _2
$a metabolomika $7 D055432
650    _2
$a metagenom $7 D054892
650    _2
$a RNA ribozomální 16S $x genetika $7 D012336
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Lexa, Matej $u Faculty of Informatics, Masaryk University, Brno, Czechia
700    1_
$a Fiedorová, Kristýna $u Centre for Cardiovascular Surgery and Transplantation, Brno, Czechia $u Department of Clinical Immunology and Allergology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Gadara, Darshak C $u RECETOX Center, Faculty of Science, Masaryk University, Brno, Czechia
700    1_
$a Micenková, Lenka $u RECETOX Center, Faculty of Science, Masaryk University, Brno, Czechia
700    1_
$a Spacil, Zdenek $u RECETOX Center, Faculty of Science, Masaryk University, Brno, Czechia
700    1_
$a Litzman, Jiří $u Department of Clinical Immunology and Allergology, Faculty of Medicine, Masaryk University, Brno, Czechia $u Department of Clinical Immunology and Allergology, St. Anne's University Hospital in Brno, Brno, Czechia
700    1_
$a Freiberger, Tomáš $u Centre for Cardiovascular Surgery and Transplantation, Brno, Czechia $u Department of Clinical Immunology and Allergology, Faculty of Medicine, Masaryk University, Brno, Czechia
700    1_
$a Šmajs, David $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czechia
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 12, č. - (2021), s. 671239
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34054845 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145322 $b ABA008
999    __
$a ok $b bmc $g 1751721 $s 1155495
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 12 $c - $d 671239 $e 20210514 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Možnosti archivace